Catabasis Pharmaceuticals Funding: $72M Raised, Series B
Catabasis Pharmaceuticals is based in Cambridge. It has raised $72M in total funding. Latest round: Series B.
Catabasis Pharmaceuticals funding overview
Catabasis Pharmaceuticals is based in Cambridge. Catabasis Pharmaceuticals has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in November 2013. The round record for Catabasis Pharmaceuticals runs through 2013; nothing later has been disclosed. Investors on record include Perceptive Advisors, RA Capital Management, Venrock Healthcare Capital Partners, Lightstone Ventures, SV Life Sciences, Clarus Ventures. 6 distinct backers are named across the disclosed rounds.
Catabasis Pharmaceuticals at a glance
Total raised
$72M
Latest round
Series B
Latest round date
November 2013
Headquarters
Cambridge
Notable investors
Perceptive Advisors, RA Capital Management, Venrock Healthcare Capital Partners, Lightstone Ventures, SV Life Sciences, Clarus Ventures
Frequently asked about Catabasis Pharmaceuticals funding
How much has Catabasis Pharmaceuticals raised?
Catabasis Pharmaceuticals has raised $72M in total disclosed funding across the rounds on record.
Who has invested in Catabasis Pharmaceuticals?
Perceptive Advisors, RA Capital Management, Venrock Healthcare Capital Partners, Lightstone Ventures, SV Life Sciences, Clarus Ventures are named among the investors backing Catabasis Pharmaceuticals.
What was the latest Catabasis Pharmaceuticals funding round?
The most recent disclosed round is a Series B, announced in November 2013.
Where is Catabasis Pharmaceuticals based?
Catabasis Pharmaceuticals is based in Cambridge.
When did Catabasis Pharmaceuticals last raise?
The last disclosed Catabasis Pharmaceuticals round closed in November 2013 at Series B.
Catabasis Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Cambridge below to benchmark round size and investor mix.
Companies related to Catabasis Pharmaceuticals (35)
